These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1353 related items for PubMed ID: 17182241

  • 21. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
    Santini D, Vincenzi B, La Cesa A, Virzi V, Navajas F, Malafarina V, Dicuonzo G, Cassandro R, Esposito V, Montesarchio V, Groeger AM, Tonini G.
    Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
    [Abstract] [Full Text] [Related]

  • 22. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia.
    Mel JR, Salar A, Rodríguez CA, Alegre A, González A, Cassinello J, Montesinos J, Gasquet JA, Sánchez J, Saigí E, AMG-DAR-2002-01 Study Group.
    Curr Med Res Opin; 2008 Oct; 24(10):2931-42. PubMed ID: 18775103
    [Abstract] [Full Text] [Related]

  • 23. High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).
    Verbeke N, Beguin Y, Wildiers H, Canon JL, Bries G, Bosly A, Van Belle S.
    Support Care Cancer; 2012 Jan; 20(1):23-8. PubMed ID: 21107613
    [Abstract] [Full Text] [Related]

  • 24. Evaluating erythropoietic agents for the treatment of anaemia in the oncology setting.
    Gascón P.
    Eur J Cancer; 2005 Nov; 41(17):2601-12. PubMed ID: 16230006
    [Abstract] [Full Text] [Related]

  • 25. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N, Fouda M.
    Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
    [Abstract] [Full Text] [Related]

  • 26. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
    Cornes P, Coiffier B, Zambrowski JJ.
    Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
    [Abstract] [Full Text] [Related]

  • 27. RETRA: evaluating the transfusion rate with darbepoetin alfa 500 µg every 3 weeks in anaemic cancer patients receiving chemotherapy.
    Eisterer W, Hussl C, Erb H, Haslbauer F, Sormann S, Braun S, Jaeger C.
    Curr Med Res Opin; 2011 Feb; 27(2):355-63. PubMed ID: 21166611
    [Abstract] [Full Text] [Related]

  • 28. Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial.
    Chen L, Jiang H, Gao W, Tu Y, Zhou Y, Li X, Zhu Z, Jiang Q, Zhan H, Yu J, Fu C, Gao Y.
    BMJ Open; 2016 Oct 07; 6(10):e012231. PubMed ID: 27855097
    [Abstract] [Full Text] [Related]

  • 29. Epoetin alfa for the treatment of cancer- and chemotherapy-related anaemia: product review and update.
    Henry DH.
    Expert Opin Pharmacother; 2005 Feb 07; 6(2):295-310. PubMed ID: 15757425
    [Abstract] [Full Text] [Related]

  • 30. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment.
    Repetto L, Moeremans K, Annemans L, European Organisation for Research and Treatment of Cancer.
    Cancer Treat Rev; 2006 Feb 07; 32 Suppl 2():S5-9. PubMed ID: 16725267
    [Abstract] [Full Text] [Related]

  • 31. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P, Kritikos K, Hatzopoulos A, Mitsibounas D.
    Eur J Cancer Care (Engl); 2008 Nov 07; 17(6):619-23. PubMed ID: 18707619
    [Abstract] [Full Text] [Related]

  • 32. Erythropoietin or darbepoetin for patients with cancer.
    Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Brunskill S, Djulbegovic B, Benett CL, Langensiepen S, Hyde C, Engert E.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD003407. PubMed ID: 16856007
    [Abstract] [Full Text] [Related]

  • 33. Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy.
    Demetri GD.
    Br J Cancer; 2001 Apr 19; 84 Suppl 1(Suppl 1):31-7. PubMed ID: 11308272
    [Abstract] [Full Text] [Related]

  • 34. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
    Shasha D, George MJ, Harrison LB.
    Cancer; 2003 Sep 01; 98(5):1072-9. PubMed ID: 12942577
    [Abstract] [Full Text] [Related]

  • 35. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N, Sriuranpong V, Suwanrusme H.
    J Med Assoc Thai; 2007 Jun 01; 90(6):1082-8. PubMed ID: 17624200
    [Abstract] [Full Text] [Related]

  • 36. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.
    Henry DH, Dahl NV, Auerbach M, Tchekmedyian S, Laufman LR.
    Oncologist; 2007 Feb 01; 12(2):231-42. PubMed ID: 17296819
    [Abstract] [Full Text] [Related]

  • 37. The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
    Borg S, Glenngård AH, Osterborg A, Persson U.
    Acta Oncol; 2008 Feb 01; 47(6):1009-17. PubMed ID: 18770060
    [Abstract] [Full Text] [Related]

  • 38. Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia.
    Steensma DP, Sloan JA, Dakhil SR, Dalton R, Kahanic SP, Prager DJ, Stella PJ, Rowland KM, Novotny PJ, Loprinzi CL.
    J Clin Oncol; 2011 Jan 01; 29(1):97-105. PubMed ID: 21098317
    [Abstract] [Full Text] [Related]

  • 39. Darbepoetin versus epoetin alfa for the correction of anemia in cancer patients receiving radiotherapy or chemoradiotherapy treatment.
    Ots PM, Carrizosa CL, Pérez AR, de Dios Saez Garrido J, Pérez JM.
    Clin Med Oncol; 2008 Jan 01; 2():393-9. PubMed ID: 21892305
    [Abstract] [Full Text] [Related]

  • 40. Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management.
    Vansteenkiste JF.
    Cancer Treat Rev; 2006 Jan 01; 32 Suppl 2():S11-5. PubMed ID: 16725268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 68.